Solid Biosciences Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Solid Biosciences Inc
CIK #0001707502
EDGAR Form CIK 2011 - 2026
10-K [0001707502]
10-Q [0001707502]
3 [0001707502]
4 [0001707502]
8-K [0001707502]
D [0001707502]
SC 13D [0001707502]
SC 13G [0001707502]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP Solid Biosciences Inc [2026-02-17]
BlackRock Inc Solid Biosciences Inc [2025-07-17]
Adage Capital Management LP Solid Biosciences Inc [2025-05-12]
Commodore Capital LP Solid Biosciences Inc [2025-02-25]
Vestal Point Capital LP Solid Biosciences Inc [2024-11-14]
Millennium Management LLC Solid Biosciences Inc [2024-06-05]
Adage Capital Partners GP LLC Solid Biosciences Inc [2024-02-07]
Artal International SCA Solid Biosciences Inc [2024-01-22]
Flynn James E Solid Biosciences Inc [2024-01-12]
Camber Capital Management LP Solid Biosciences Inc [2022-12-12]
View All
Form 3/4/5 Subject 2011 - 2026
Solid Biosciences Inc
Smith Ian F
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
Nagendran Sukumar
Stone Adam Leo
Sullivan Lynne Marie
Kahn Clare
Freed Martin I
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Keresty Georgia
Ganot Ilan
Herzich Paul
Brooks Gabriel
Cumbo Alexander
Tan Kevin
Howton David T
Hanrahan Jessie
Perceptive Xontogeny Venture Fund LP
Bain Capital Life Sciences Investors II LLC
BCIP Life Sciences Associates LP
BCLS II Investco GP LLC
BCLS SB Investco LP
Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund II LP
Bain Capital Life Sciences Partners LP
BCLS II Equity Opportunities GP LLC
BCLS II Equity Opportunities LP
BCLS II Investco LP
Atchinson Robert
Adage Capital Management LP
Gross Phillip
Marlowe Jennifer
RA Capital Nexus Fund LP
Koppel Adam
Morris Carl Ashley
Huffines Robert Luther
Perceptive Venture Advisors LLC
Brennan Erin Powers
Schneider Joel Solomon Zev
DiPalma Stephen J
Ziolkowski Jennifer Lynn
Arnold Matthew Bennett
Ultragenyx Pharmaceutical Inc
Herscha Lynette
Zarur Juan Andrey
Boxer Capital LLC
Braslyn Ltd
Lewis Joseph
MVA Investors LLC
Boxer Asset Management Inc
Quiroz Jorge Armando
Amorrortu Pedro Alvaro
Hayeem Gilad David
JPMC Strategic Investments II Corp
JPMorgan Chase & Co
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Solid Biosciences Inc SLDB
Pre-Funded Warrant (right to buy) · derivative
2026-03-09 Grant 8,912,655 $5.61 49,999,995
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 5,404 $5.82 31,451
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 4,134 $5.82 24,060
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 0 $5.82
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 7,469 $5.82 43,470
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 3,616 $5.82 21,045
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 2,658 $5.82 15,470
Solid Biosciences Inc SLDB
Common Stock
2026-02-18 Sell 16,644 $5.82 96,868
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 30,031
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 10,937
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 7,187
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 10,625
Solid Biosciences Inc SLDB
Restricted Stock Units · derivative
2026-02-13 Option exercise 7,187 $0.00
Solid Biosciences Inc SLDB
Restricted Stock Units · derivative
2026-02-13 Option exercise 30,031 $0.00
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 4,861
Solid Biosciences Inc SLDB
Restricted Stock Units · derivative
2026-02-13 Option exercise 4,861 $0.00
Solid Biosciences Inc SLDB
Restricted Stock Units · derivative
2026-02-13 Option exercise 10,937 $0.00
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 14,687
Solid Biosciences Inc SLDB
Common Stock
2026-02-13 Option exercise 8,125
Solid Biosciences Inc SLDB
Restricted Stock Units · derivative
2026-02-13 Option exercise 14,687 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com